The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention

By Rittig K.   Thamer C.   Machicao F.   Rietig R.   Stefan N.   Fritsche A.   Haring H.-U.   Balletshofer B.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1345-1347

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Risk of Osteopenia in β-Thalassemia Major Patients

By Sahmani Mehdi   Gholami Abdollah   Azarkeivan Azita   Darabi Masoud   Ahmadi Mohammad Hossein   Sabet Majid Sirati   Najafipour Reza  

Hemoglobin, Vol. 37, Iss. 6, 2013-12 ,pp. : 564-573

Informa Healthcare

Access to resources Recommend Favorite

Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes

By Doney A.   Fischer B.   Cecil J.   Boylan K.   McGuigan F.   Ralston S.   Morris A.   Palmer C.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 555-558

Springer Publishing Company

Access to resources Recommend Favorite

Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland

By Pechère Antoinette   Greminger Peter   Hess Lorenzo   Philippe Jacques   Ferrari Paolo  

Blood Pressure, Vol. 14, Iss. 6, 2005-12 ,pp. : 337-344

Informa Healthcare

Access to resources Recommend Favorite

Effects of a 12-month physical activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes

By Kirk A.   Mutrie N.   MacIntyre P.   Fisher M.  

Diabetologia, Vol. 47, Iss. 5, 2004-05 ,pp. : 821-832

Springer Publishing Company

Access to resources Recommend Favorite